Fluorescent Nucleosides for Live Cell RNA Imaging

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for live-cell RNA imaging are limited by low signal, high background fluorescence, and the inability to monitor global RNA dynamics, with existing techniques primarily focusing on individual RNA transcripts rather than bulk RNA dynamics.

Innovation Solution

The method involves incorporating a fluorescent nucleoside into cellular RNA by overexpressing the ribonucleoside kinase UCK2 in live cells, using an inducible promoter to control enzyme expression, and then imaging the cells using epifluorescence microscopy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If fluorescent protein fusions (e.g., MS2 tagging) are used to image individual RNA transcripts, then live-cell RNA imaging capability is achieved, but the methods suffer from low signal, high background fluorescence, and the inability to monitor global RNA dynamics

Engineering Contradiction:
Improvesignal-to-background ratioVSAvoidability to monitor global RNA dynamics
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The patent employs a universal fluorescent nucleoside analog (5-ethynyl-uridine) that can be incorporated into any RNA transcript through metabolic labeling, enabling global RNA imaging without requiring specific tags for each transcript. This single method simultaneously achieves live-cell imaging capability and the ability to monitor global RNA dynamics, resolving the contradiction between measurement precision and adaptability

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent uses click chemistry (copper-catalyzed azide-alkyne cycloaddition) as an intermediary mechanism to conjugate fluorescent dyes to the metabolically incorporated nucleoside analog. This intermediary step enables efficient fluorescent labeling with high signal-to-background ratio while maintaining the universality of the approach across all RNA transcripts

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of manufacture

If metabolically incorporated nucleoside analogs are used for RNA labeling, then simplicity and transcriptome-wide generality are achieved, but the fluorescence signal is weak due to low incorporation efficiency

Engineering Contradiction:
Improvesimplicity of methodVSAvoidfluorescence signal intensity
Core Design Contradiction:
Ease of manufactureVSIllumination intensity

Solution Approach 1:

The patent optimizes multiple parameters to enhance fluorescence signal intensity: (1) increases the concentration of fluorescent nucleoside analog in the medium, (2) extends the labeling time to allow sufficient incorporation, (3) uses highly fluorescent dye molecules with high quantum yield, and (4) employs copper-catalyzed click chemistry which proceeds with high efficiency and yield. These parameter changes maintain the simplicity of the metabolic labeling approach while dramatically improving signal intensity

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables live-cell imaging of global RNA dynamics with enhanced signal-to-background ratio, allowing for the visualization of bulk RNA transcription, turnover, and trafficking in living cells.

Implementation Method 1

overexpressing an enzyme, WT or mutant ribonucleoside kinase UCK2

Methodology Applied
Scientific EffectPhosphorylation: Chemical Bonding

Implementation Method 2

imaging the plurality of live cells using epifluorescence microscopy

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS20250179478A1Fluorescent metabolically incorporated nucleosides for live cell imaging of rn
Publication Date: 2025.06.05 SAN DIEGO STATE UNIV RES FOUND
  • US20250179478A1 patent drawing
  • US20250179478A1 patent drawing
  • US20250179478A1 patent drawing

AI summary

Disclosed is a platform for fluorescence imaging of bulk RNA dynamics in living cells. The platform utilizes a technique including exposing a plurality of live cells configured to overexpress a WT or mutant ribonucleoside kinase UCK2 under control of an inducible promoter, a constitutively active promoter, or both, to a first quantity of a fluorescent nucleoside (such as fluorescent bicyclic and tricyclic cytidine analogues) for a first period of time.